Covered recipient · General Payments record
JULIE BELNAP
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2024
$409.81
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.70 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $199.27 | 19 |
| Novo Nordisk AS | $47.12 | 3 |
| Axsome Therapeutics, Inc. | $17.47 | 1 |
| PFIZER INC. | $16.50 | 1 |
| Janssen Pharmaceuticals, Inc | $15.05 | 1 |
| Amgen Inc. | $14.26 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.96 | 1 |
| Acerta Pharma LLC | $13.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.25 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510278 | CMS |
| ABBVIE INC. | $6.64 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510280 | CMS |
| ABBVIE INC. | $67.04 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510282 | CMS |
| ABBVIE INC. | $15.64 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510284 | CMS |
| ABBVIE INC. | $7.09 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510286 | CMS |
| ABBVIE INC. | $10.66 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510288 | CMS |
| ABBVIE INC. | $6.55 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510290 | CMS |
| ABBVIE INC. | $4.20 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510292 | CMS |
| ABBVIE INC. | $6.66 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510294 | CMS |
| ABBVIE INC. | $5.47 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510296 | CMS |
| ABBVIE INC. | $2.18 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510298 | CMS |
| ABBVIE INC. | $10.21 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510300 | CMS |
| ABBVIE INC. | $5.41 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510302 | CMS |
| ABBVIE INC. | $2.84 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510304 | CMS |
| ABBVIE INC. | $12.92 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510306 | CMS |
| ABBVIE INC. | $7.09 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510308 | CMS |
| ABBVIE INC. | $15.42 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510310 | CMS |
| ABBVIE INC. | $3.29 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510312 | CMS |
| ABBVIE INC. | $4.71 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106510314 | CMS |
| Amgen Inc. | $14.26 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117504848 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.07 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105597315 | CMS |
| Axsome Therapeutics, Inc. | $17.47 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148373137 | CMS |
| Janssen Pharmaceuticals, Inc | $15.05 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078021810 | CMS |
| Novo Nordisk Inc | $15.04 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100473131 | CMS |
| Novo Nordisk Inc | $15.22 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100340962 | CMS |
| Novo Nordisk Inc | $16.86 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100572478 | CMS |
| PFIZER INC. | $16.50 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131696507 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.96 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153414663 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.